Marion Odence-Ford - Nov 8, 2021 Form 4 Insider Report for OptimizeRx Corp (OPRX)

Role: General Counsel and CCO
Signature: /s/ Marion Odence-Ford
Stock symbol: OPRX
Transactions as of: Nov 8, 2021
Transactions value $: $0
Form type: 4
Date filed: 11/10/2021, 03:45 PM
Next filing: Feb 15, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OPRX	Stock Option	Award	$0	-11K	-50%	$0.00	11K	Nov 8, 2021	Common Stock	11K	$93.37	Direct	F1
transaction	OPRX	Restricted Stock Units	Award	$0	-5.36K	-17.45%	$0.00	25.3K	Nov 8, 2021	Common Stock	5.34K		Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Stock Option will vest 1/3 at the end of each anniversary from issuance.
F2	Each restricted stock unit represents a contingent right to receive one share of the OptimizeRx's common stock. The restricted stock units will vest 1/3 at the end of each anniversary from issuance. Any restricted stock unit that has not been earned and vested as of the third anniversary of the grant date will be forfeited. Vesting of the restricted stock units shall accelerate upon a qualifying termination.

Content

The Stock Option will vest 1/3 at the end of each anniversary from issuance.

Each restricted stock unit represents a contingent right to receive one share of the OptimizeRx's common stock. The restricted stock units will vest 1/3 at the end of each anniversary from issuance. Any restricted stock unit that has not been earned and vested as of the third anniversary of the grant date will be forfeited. Vesting of the restricted stock units shall accelerate upon a qualifying termination.